3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
14
Lung Neoplasms
13
Colorectal Neoplasms
13
Lymphoma
5
Hematologic Neoplasms
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Hematopoietic and Lymphatic System Neoplasm
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Papillomavirus Infections
3
Pancreatic Neoplasms
3
Obesity-Related Malignant Neoplasm
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Neoplasms
2
Multiple Myeloma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Endometrial Neoplasms
2
Breast Carcinoma In Situ
2
Advanced Malignant Solid Neoplasm
2
Vulvar Neoplasms
1
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
20
pomalidomide
18
Lenalidomide
17
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Cisplatin
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Carboplatin
7
zanubrutinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Early Intervention, Educational
×
1 year
×
Clear all
No trials found.